𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction

✍ Scribed by Dr. Sabyasachi Ganguly; Vundavalli V. V. S. Murty; Felipe Samaniego; Victor E. Reuter; George J. Bosl; R. S. K. Chaganti


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
383 KB
Volume
1
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


We have studied 3 I male germ cell tumors (GCTs) for probable mutations in codons 12, 13, and 6 I of HRAS, KRAS, and NRAS oncogenes using the polymerase chain reaction. Twenty of the thirty-one tumors exhibited NRAS gene mutations, 14 in codon 6 I, and six in codon 12, whereas no mutations were detected in HRAS and KRAS genes. The NRAS mutations were equally prevalent in seminomatous and nonseminomatous GCTs. Thus I 3 of 22 seminomas, six of seven embryonal carcinomas, and one of two mixed tumors exhibited mutations. Two non-seminomatous tumors (an embryonal carcinoma and a yolk sackeratoma) had mutations in both codons I 2 and 6 I. The high frequency of NRAS mutations observed in the present study suggests that NRAS gene products may play an important role in growth regulatory functions of premalignant and malignant germ cells.


πŸ“œ SIMILAR VOLUMES


Polymerase chain reaction in the detecti
✍ Ronald A. Ghossein; Juan Rosai πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 737 KB

## BACKGROUND. The sensitive detection of circulating tumor cells and micrometastases may have important therapeutic and prognostic implications. METHODS. The molecular detection of occult tumor cells can be accomplished by amplifying tumor specific abnormalities present in the DNA or mRNA of mali

Rare mutations of the Gs alpha subunit g
✍ Katsuhiko Yoshimoto; Hiroyuki Iwahana; Ayumi Fukuda; Toshiaki Sano; Mitsuo Itaku πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 785 KB

Background. The Gs alpha (Gsa) gene can be activated to the putative oncogene gsp by specific point mutations at codons 201 or 227. Such mutations have been reported in growth hormone (GH)-secreting pituitary adenomas and thyroid tumors. To clarify the role of Gsa gene in human endocrine tumors, 197